These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Effect of histamine-sensitizing factor of Bordetella pertussis on pharmacologic response of rat atria. Endoh M; Nakase Y Microbiol Immunol; 1982; 26(2):119-27. PubMed ID: 6283322 [TBL] [Abstract][Full Text] [Related]
23. Immunologic and biochemical properties of the histamine-sensitizing factor from Bordetella pertussis. Lehrer SB; Vaughan JH; Tan EM J Immunol; 1975 Jan; 114(1 Pt 1):34-9. PubMed ID: 46244 [TBL] [Abstract][Full Text] [Related]
24. Angiogenesis is regulated by angiopoietins during experimental autoimmune encephalomyelitis and is indirectly related to vascular permeability. Macmillan CJ; Starkey RJ; Easton AS J Neuropathol Exp Neurol; 2011 Dec; 70(12):1107-23. PubMed ID: 22082662 [TBL] [Abstract][Full Text] [Related]
25. Prazosin treatment during the effector stage of disease suppresses experimental autoimmune encephalomyelitis in the Lewis rat. Brosnan CF; Sacks HJ; Goldschmidt RC; Goldmuntz EA; Norton WT J Immunol; 1986 Dec; 137(11):3451-6. PubMed ID: 3491136 [TBL] [Abstract][Full Text] [Related]
26. Reaginic antibody in experimental allergic encephalomyelitis. II. Histamine and serotonin blockade. Moore MJ; Matthews JM; Matthews TK; Behan PO; Kies MW Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):133-44. PubMed ID: 4140560 [No Abstract] [Full Text] [Related]
27. Experimental allergic encephalitis (EAE) in mice: histological studies on EAE induced by myelin basic protein, and role of pertussis vaccine. Mitsuzawa E; Yasuda T Jpn J Exp Med; 1976 Aug; 46(4):205-12. PubMed ID: 62860 [TBL] [Abstract][Full Text] [Related]
28. Genetic analysis of the influence of pertussis toxin on experimental allergic encephalomyelitis susceptibility: an environmental agent can override genetic checkpoints. Blankenhorn EP; Butterfield RJ; Rigby R; Cort L; Giambrone D; McDermott P; McEntee K; Solowski N; Meeker ND; Zachary JF; Doerge RW; Teuscher C J Immunol; 2000 Mar; 164(6):3420-5. PubMed ID: 10706738 [TBL] [Abstract][Full Text] [Related]
29. Pleurorrhea-inducing activity of the histamine-sensitizing factor of Bordetella pertussis. Endoh M; Fujimoto T; Nakase Y Microbiol Immunol; 1983; 27(11):979-84. PubMed ID: 6321914 [No Abstract] [Full Text] [Related]
30. Glycerol-releasing activity of histamine-sensitizing factor of Bordetella pertussis for rat adipocytes in vitro. Endoh M; Nakase Y Microbiol Immunol; 1982; 26(8):689-703. PubMed ID: 6294484 [TBL] [Abstract][Full Text] [Related]
31. An electrophysiological model of spinal transmission deficits in mouse experimental autoimmune encephalomyelitis. Hanak SE; Reilly EM; Wotanis J; Zhu B; Pulicicchio C; McMonagle-Strucko K; Wettstein JG; Black MD J Pharmacol Exp Ther; 2004 Jan; 308(1):214-20. PubMed ID: 14566007 [TBL] [Abstract][Full Text] [Related]
32. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis. Alt C; Laschinger M; Engelhardt B Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625 [TBL] [Abstract][Full Text] [Related]
33. Endothelial histamine H1 receptor signaling reduces blood-brain barrier permeability and susceptibility to autoimmune encephalomyelitis. Lu C; Diehl SA; Noubade R; Ledoux J; Nelson MT; Spach K; Zachary JF; Blankenhorn EP; Teuscher C Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18967-72. PubMed ID: 20956310 [TBL] [Abstract][Full Text] [Related]
34. Hyperacute allergic encephalomyelitis. A localized form produced by passive transfer and pertussis vaccine. Levine S; Sowinski R Am J Pathol; 1973 Oct; 73(1):247-60. PubMed ID: 4584127 [TBL] [Abstract][Full Text] [Related]
36. Assay of pertussis vaccine reactivity factors by measurement of the paw swelling response, endotoxin and histamine-sensitizing factor. Vuolo AM; Lustigman B Biologicals; 1993 Mar; 21(1):45-52. PubMed ID: 8217117 [TBL] [Abstract][Full Text] [Related]
37. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment. Castro SB; Junior CO; Alves CC; Dias AT; Alves LL; Mazzoccoli L; Mesquita FP; Figueiredo NS; Juliano MA; CastaƱon MC; Gameiro J; Almeida MV; Teixeira HC; Ferreira AP Int Immunopharmacol; 2012 Feb; 12(2):465-70. PubMed ID: 22245971 [TBL] [Abstract][Full Text] [Related]
38. In vitro induction of altered response of rat atria to acetylcholine with histamine-sensitizing factor of Bordetella pertussis. Endoh M; Nakase Y Microbiol Immunol; 1983; 27(2):131-6. PubMed ID: 6306409 [TBL] [Abstract][Full Text] [Related]
39. Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis. Bergman RK; Munoz JJ; Portis JL Infect Immun; 1978 Aug; 21(2):627-37. PubMed ID: 211087 [TBL] [Abstract][Full Text] [Related]
40. Distribution of radioactivity in rats injected intravenously with 125I-labeled histamine-sensitizing factor of Bordetella pertussis. Endoh M; Fujimoto T; Nakase Y Microbiol Immunol; 1984; 28(2):233-6. PubMed ID: 6328231 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]